Zoetis Inc. (ZTS)
NYSE: ZTS · Real-Time Price · USD
124.70
-0.59 (-0.47%)
Jan 16, 2026, 10:58 AM EST - Market open
Zoetis Revenue
Zoetis had revenue of $2.40B in the quarter ending September 30, 2025, with 0.50% growth. This brings the company's revenue in the last twelve months to $9.40B, up 2.68% year-over-year. In the year 2024, Zoetis had annual revenue of $9.26B with 8.33% growth.
Revenue (ttm)
$9.40B
Revenue Growth
+2.68%
P/S Ratio
5.95
Revenue / Employee
$680,942
Employees
13,800
Market Cap
54.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.26B | 712.00M | 8.33% |
| Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
| Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
| Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
| Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
| Dec 31, 2019 | 6.26B | 435.00M | 7.47% |
| Dec 31, 2018 | 5.83B | 518.00M | 9.76% |
| Dec 31, 2017 | 5.31B | 419.00M | 8.57% |
| Dec 31, 2016 | 4.89B | 123.00M | 2.58% |
| Dec 31, 2015 | 4.77B | -20.00M | -0.42% |
| Dec 31, 2014 | 4.79B | 224.00M | 4.91% |
| Dec 31, 2013 | 4.56B | 225.00M | 5.19% |
| Dec 31, 2012 | 4.34B | 103.00M | 2.43% |
| Dec 31, 2011 | 4.23B | 651.00M | 18.17% |
| Dec 31, 2010 | 3.58B | 822.00M | 29.78% |
| Dec 31, 2009 | 2.76B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ZTS News
- 2 days ago - Zoetis: Cheap Valuation And Attractive Product Launch Pipeline - Seeking Alpha
- 3 days ago - Zoetis Inc. (ZTS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 18 days ago - These stocks fell hard in 2025, but analysts see as much as 65% upside for them in 2026 - Market Watch
- 4 weeks ago - Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 4 weeks ago - Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering - Business Wire
- 4 weeks ago - Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering - Business Wire
- 4 weeks ago - Gabelli Pet Parents' Fund Q3 2025 Contributors And Detractors - Seeking Alpha